Home
Conditions
Blood-Borne Infections

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,276 public trials 443 recruiting studies

Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

IMPAACT P1058A: Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults

NCT00977756

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Univ. of Alabama Birmingham NICHD CRS (5096) Birmingham, Alabama, United States

Miller Children's Hospital Long Beach, CA NICHD CRS (5093) Long Beach, California, United States

Usc La Nichd Crs (5048) Los Angeles, California, United States

UCSD Mother, Child & Adolescent HIV Program(4601) San Diego, California, United States

View all 35 locations

View Trial Details

Completed

Biliverdin Reductase A in Chronic Hepatitis C Virus Infection

NCT01112033

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Institute of Clinical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University in Prague Prague, Czechia

View Trial Details

Completed

Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort."

NCT02196064

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
Locations: Fundación Pública Andaluza Progreso y Salud Seville, Sevilla, Spain

View Trial Details

Completed

Drug Interaction Study With BI 201335 and Methadone or Buprenorphine/Naloxone

NCT01637922

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: 1220.57.0001 Boehringer Ingelheim Investigational Site Atlanta, Georgia, United States

1220.57.0002 Boehringer Ingelheim Investigational Site Overland Park, Kansas, United States

1220.57.0003 Boehringer Ingelheim Investigational Site Salt Lake City, Utah, United States

View Trial Details

Completed

Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects

NCT00654147

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: University of Miami AIDS Clinical Research Unit Miami, Florida, United States

View Trial Details

Completed

Japanese Pegylated Interferon (PegIFN) Alfa-2b/Ribavirin (RBV) Combination Trial

NCT01579474

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: 1220.54.08104 Boehringer Ingelheim Investigational Site Chuo-ku, Chiba, Japan

1220.54.08118 Boehringer Ingelheim Investigational Site Chuo-ku, Kobe, Hyogo, Japan

1220.54.08108 Boehringer Ingelheim Investigational Site Fukui, Fukui, Japan

1220.54.08110 Boehringer Ingelheim Investigational Site Gifu, Gifu, Japan

View all 24 locations

View Trial Details

Completed

Drug-drug Interaction of BI 201335 and Microgynon

NCT01570244

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: 1220.56.1 Boehringer Ingelheim Investigational Site Biberach, Germany

View Trial Details

Completed

Effect of Multiple Dosing With BI 201335 on the Pharmacokinetics of Darunavir Co-administered With Ritonavir in Healthy Male and Female Volunteers

NCT01374802

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: 1220.49.1 Boehringer Ingelheim Investigational Site Berlin, Germany

View Trial Details

Completed

Drug Drug Interaction of BI 201335 and Tenofovir

NCT01340196

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: 1220.50.0001 Boehringer Ingelheim Investigational Site Buffalo, New York, United States

View Trial Details

Completed

Bioequivalence Trial of 2 Dose Strengths of BI 201335 NA Soft Gelatine Capsules

NCT01704846

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: 1220.53.08101 Boehringer Ingelheim Investigational Site Sumida-ku,Tokyo, Japan

View Trial Details

Blood-Borne Infections

Blood-Borne Infections trial results

Related conditions